Ganaxolone: A Review in Epileptic Seizures Associated with Cyclin-Dependent Kinase-Like 5 Deficiency Disorder
Sheridan M. Hoy
No information about this author
Pediatric Drugs,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 10, 2025
Language: Английский
Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey
Epilepsia Open,
Journal Year:
2024,
Volume and Issue:
9(3), P. 832 - 849
Published: March 7, 2024
Abstract
Cyclin‐dependent
kinase‐like
5
(CDKL5)
deficiency
disorder
(CDD)
is
a
developmental
and
epileptic
encephalopathy
caused
by
variants
in
the
CDKL5
gene.
The
characterized
intractable
early‐onset
seizures,
severe
neurodevelopmental
delay,
hypotonia,
motor
disabilities,
cerebral
(cortical)
visual
impairment
microcephaly.
With
no
disease‐modifying
therapies
available
for
CDD,
treatment
symptomatic
with
an
initial
focus
on
seizure
control.
Another
unmet
need
management
of
people
CDD
lack
evidence
to
aid
standardized
care
guideline
development.
To
address
this
gap,
experts
representatives
from
patient
advocacy
groups
Denmark,
Finland,
France,
Germany,
Italy,
Poland,
Spain,
United
Kingdom
convened
form
Expert
Working
Group.
aim
was
provide
expert
opinion
consensus
how
ensure
quality
routine
clinical
practice
within
European
setting,
including
settings
limited
experience
or
resources
multidisciplinary
other
encephalopathies.
By
means
one‐to‐one
interviews
around
current
landscape
insights
Group
were
collated
developed
into
Europe‐specific
journey
individuals
which
later
validated
group.
Further
discussions
followed
gain
opinions
challenges
potential
solutions
achieving
setting.
panel
recognized
benefit
early
genetic
testing,
holistic
personalized
approach
control
(taking
consideration
various
factors
such
as
concomitant
medications
comorbidities),
age‐
comorbidity‐dependent
optimizing
outcomes
life.
However,
their
experiences
also
highlighted
much
disparity
approaches
across
different
countries.
Development
recommendations
required
align
realistic
diagnostic
criteria,
goals,
that
can
be
adapted
settings.
Plain
language
summary
rare
condition
mutation
broad
range
symptoms
apparent
childhood,
seizures
do
not
respond
medication
delays
Due
guidance
managing
international
advocates
discussed
best
practices
Europe.
agreed
access
disciplines
are
beneficial.
guidelines
would
valuable.
Language: Английский
Italian report on RARE epilepsies (i‐RARE): A consensus on multidisciplinarity
Epilepsia Open,
Journal Year:
2024,
Volume and Issue:
9(5), P. 1857 - 1867
Published: Aug. 23, 2024
Abstract
Objective
Rare
and
complex
epilepsies
encompass
a
diverse
range
of
disorders
characterized
by
seizures.
We
aimed
to
establish
consensus
on
key
issues
related
these
conditions
through
collaboration
among
experienced
neurologists,
neuropediatricians,
patient
advocacy
representatives.
Methods
Employing
modified
Delphi
method,
scientific
board
comprising
20
physicians
4
representatives
synthesized
existing
literature
with
their
expertise
formulate
statements
contentious
topics.
A
final
32‐member
expert
panel,
representing
regions
Italy,
validated
two‐round
voting
process,
defined
as
an
average
score
≥7.
Results
Sixteen
reached
consensus,
emphasizing
the
necessity
for
epidemiological
studies
ascertain
true
prevalence
rare
epilepsies.
Etiology
emerged
crucial
factor
influencing
therapeutic
strategies
outcome
prediction,
particular
concern
regarding
prolonged
tonic–clonic
The
importance
early
implementation
specific
drugs
non‐pharmacological
interventions
in
treatment
algorithm
developmental
epileptic
encephalopathies
(DEEs)
was
underscored.
Multidisciplinary
care
involving
experts
skills
deemed
essential,
non‐seizure
outcomes
adolescence
adulthood.
Significance
This
national
underscores
imperative
personalized,
comprehensive,
multidisciplinary
management
epilepsies/DEEs.
It
advocates
increased
research,
particularly
epidemiology
approaches,
inform
clinical
decision‐making
healthcare
policies,
ultimately
enhancing
patients'
outcomes.
Plain
Language
Summary
method
is
broadly
used
evaluate
debated
In
this
work,
we
sought
integrated
social
epilepsy
management.
Both
high‐level
centers
caregivers
were
directly
involved.
Language: Английский